Latest Breaking News On - Mulisystem inflammatory syndrome - Page 1 : comparemela.com

‘Children are not left out of this mix’: Charlotte pediatrician weighs in on children participating in Moderna vaccine study ‘Children are not left out of this mix’: Charlotte pediatrician weighs in on children participating in Moderna vaccine study By Courtney Cole | March 16, 2021 at 10:29 PM EDT - Updated March 16 at 11:50 PM CHARLOTTE, N.C. (WBTV) - While the COVID-19 vaccine has been focused on adults and teenagers, younger children are now being considered. Moderna Inc. announced Tuesday that the first participants have been dosed in the Phase 2/3 study, called the KidCOVE study, of mRNA-1273, the Company’s vaccine candidate against COVID-19, in children ages 6 months to less than 12 years.

United statesRochelle wilenskyBiomedical advanced researchNational institute of allergyUs department of healthHuman servicesNational institutes of healthDevelopment authorityOffice of theModerna incLaura sinaiMulisystem inflammatory syndromeNational instituteInfectious diseasesNational institutesCovid 19